Louise Ziegler

Publikationer
CV
Populärvetenskap och samverkan

Utvalda publikationer

Article: CARDIOVASCULAR RESEARCH. 2023;119(16):2594-2606

A machine learning based approach to identify carotid subclinical atherosclerosis endotypes

Chen QS; Bergman O; Ziegler L; Baldassarre D; Veglia F; Tremoli E; Strawbridge RJ; Gallo A; Pirro M; Smit AJ; Kurl S; Savonen K; Lind L; Eriksson P; Gigante B
Article: JOURNAL OF MEDICAL VIROLOGY. 2021;93(10):5908-5916

Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers

Lundstrom A; Ziegler L; Havervall S; Rudberg A-S; von Meijenfeldt F; Lisman T; Mackman N; Sanden P; Thalin C

Artiklar

Article: PSYCHONEUROENDOCRINOLOGY. 2024;164:107008

A novel biomarker of interleukin 6 activity and clinical and cognitive outcomes in depression

Foley EM; Slaney C; Donnelly NA; Kaser M; Ziegler L; Khandaker GM
Journal article: BRAIN BEHAVIOR AND IMMUNITY. 2023;114:44

A novel marker of interleukin 6 activity and clinical and cognitive outcomes in depression

Foley ÉM; Slaney C; Kaser M; Ziegler L; Khandaker G
Journal article: ALZHEIMERS & DEMENTIA. 2023;19(S8)

Temporal trends in the incidence of atrial fibrillation‐related strokes in Sweden, 2001‐2020

Ding M; Wennberg AM; Ziegler LD; Modig K
Article: LANCET REGIONAL HEALTH-EUROPE. 2023;28:100596

Time trends in atrial fibrillation-related stroke during 2001-2020 in Sweden: a nationwide, observational study

Ding M; Ebeling M; Ziegler L; Wennberg A; Modig K
Journal article: NEUROSCIENCE APPLIED. 2023;2:102449

A novel marker of interleukin 6 activity and clinical and cognitive outcomes in depression

Foley ÉM; Slaney C; Kaser M; Barnes NM; Ziegler L; Khandaker GM
Article: CYTOKINE. 2022;159:156020

IL-6 signalling biomarkers in hospitalised patients with moderate to severe SARS-CoV-2 infection in a single centre study in Sweden

Ziegler L; Lundstrom A; Havervall S; Thalin C; Gigante B
Journal article: EUROPEAN HEART JOURNAL. 2021;42(Supplement_1):ehab724.2510

IL6 trans-signalling is associated with a higher risk of cardiovascular events in individuals with diabetes

Ziegler L; Gigante B
Article: OPEN HEART. 2021;8(2):e001694

Interleukin 6 trans-signalling and the risk of future cardiovascular events in men and women

Miri Y; Leander K; Eriksson P; Gigante B; Ziegler L
Article: BMC NEUROLOGY. 2021;21(1):306

IL6 trans-signaling associates with ischemic stroke but not with atrial fibrillation

Ziegler L; Wallen H; Aspberg S; de Faire U; Gigante B
Article: VASCULAR MEDICINE. 2021;26(1):3-10

Expression of Interleukin 6 signaling receptors in carotid atherosclerosis

Ziegler L; Lundqvist J; Dreij K; Wallen H; de Faire U; Paulsson-Berne G; Hedin U; Matic L; Gigante B
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2020;27(2):122-129

The predictive role of interleukin 6 trans-signalling in middle-aged men and women at low-intermediate risk of cardiovascular events

Ziegler L; Frumento P; Wallen H; de Faire U; Gigante B
Journal article: EUROPEAN HEART JOURNAL. 2019;40(Supplement_1):ehz748.0281

P1519IL6 trans-signalling affects risk of cardiovascular events pre-eminently in men

Ziegler L; Frumento P; Wallen H; De Faire U; Gigante B
Article: BMC GERIATRICS. 2019;19(1):31

Temporal trends in incidence, recurrence and prevalence of stroke in an era of ageing populations,a longitudinal study of the total Swedish population

Modig K; Talback M; Ziegler L; Ahlbom A
Article: CARDIOVASCULAR RESEARCH. 2019;115(1):213-221

Interleukin 6 trans-signalling and risk of future cardiovascular events

Ziegler L; Gajulapuri A; Frumento P; Bonomi A; Wallen H; de Faire U; Rose-John S; Gigante B
Journal article: EUROPEAN HEART JOURNAL. 2018;39(suppl_1):ehy565.p2625

P2625The soluble IL6 receptor and ischemic cerebrovascular disease

Ziegler L; Lundqvist J; Perisic L; Gajulapuri A; Dreij K; Frumento P; Paulsson-Berne G; Wallen H; De Faire U; Hedin U; Gigante B
Journal article: REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE. 2018;66:s366

Incidence, recurrence and prevalence of stroke in an ageing population

Modig K; Ahlbom A; Talback M; Ziegler L
Journal article: EUROPEAN HEART JOURNAL. 2017;38(suppl_1):ehx504.4159

4159The soluble IL6 receptor as a predictor for early cardiovascular events

Ziegler L; Gajulapuri A; Frumento P; Wallen H; De Faire U; Gigante B

Alla övriga publikationer

Corrigendum: BMC NEUROLOGY. 2022;22(1):337

IL6 trans-signaling associates with ischemic stroke but not with atrial fibrillation (vol 21, 306, 2021)

Ziegler L; Wallen H; Aspberg S; de Faire U; Gigante B
Review: EUROPEAN CARDIOLOGY. 2022;17:e09

Circulating Biomarkers in Lower Extremity Artery Disease

Ziegler L; Hedin U; Gottsater A
Preprint: SSRN ELECTRONIC JOURNAL. 2022

Time Trends in Atrial Fibrillation-Related Stroke in an Era of Declining Stroke - A Swedish Nationwide Register-Based Study

Ding M; Ebeling M; Ziegler L; Wennberg A; Modig K
Preprint: MEDRXIV. 2021

Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers

Lundström A; Ziegler L; Havervall S; Rudberg A-S; von Meijenfeldt F; Lisman T; Mackman N; Sandén P; Thålin C
Conference publication: EUROPEAN HEART JOURNAL. 2021;42:2510

IL6 trans-signalling is associated with a higher risk of cardiovascular events in individuals with diabetes

Ziegler L; Gigante B
Conference publication: EUROPEAN HEART JOURNAL. 2020;41:2365

IL6 trans-signalling associates with atherothrombotic but not with cardioembolic stroke

Ziegler L; Wallen H; Aspberg S; De Faire U; Gigante B
Thesis / dissertation: 2020

Interleukin 6 trans-signalling : cardiovascular risk marker or therapeutical target?

Ziegler, Louise
Conference publication: INTERNATIONAL JOURNAL OF STROKE. 2020;15(1_SUPPL):50

PRO-INFLAMMATORY IL6 TRANS-SIGNALLING IS ASSOCIATED WITH ISCHEMIC STROKE BUT NOT WITH ATRIAL FIBRILLATION

Ziegler L
Conference publication: EUROPEAN HEART JOURNAL. 2019;40:824

IL6 trans-signalling affects risk of cardiovascular events pre-eminently in men

Ziegler L; Frumento P; Wallen H; De Faire U; Gigante B
Conference publication: EUROPEAN HEART JOURNAL. 2018;39:524-525

The soluble IL6 receptor and ischemic cerebrovascular disease

Ziegler L; Lundqvist J; Perisic L; Gajulapuri A; Dreij K; Frumento P; Paulsson-Berne G; Wallen H; De Faire U; Hedin U; Gigante B
Conference publication: EUROPEAN HEART JOURNAL. 2017;38:857

The soluble IL6 receptor as a predictor for early cardiovascular events

Ziegler L; Gajulapuri A; Frumento P; Wallen H; De Faire U; Gigante B

Anställningar

Överläkare, Internmedicin och vaskulär medicin, Neurologkliniken, Danderyds sjukhus, 2024-
Anknuten till Forskning, Kliniska vetenskaper, Danderyds sjukhus, Karolinska Institutet, 2023-2026

Examina och utbildning

Medicine Doktorsexamen, Institutionen för kliniska vetenskaper, Danderyds sjukhus, Karolinska Institutet, 2020

Utvalda publikationer

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI